ProShares Ultra Nasdaq Biotechnology (BIB)

NASDAQ: BIB · Real-Time Price · USD

80.64

-1.45 (-1.77%)

Apr 28, 2026, 4:00 PM EDT - Market closed

-1.77% (1D)

Assets	$85.89M
Expense Ratio	0.95%
PE Ratio	n/a
Shares Out	940,000
Dividend (ttm)	$0.49
Dividend Yield	0.61%
Ex-Dividend Date	Mar 25, 2026
Payout Frequency	Quarterly
Payout Ratio	n/a

Volume	4,416
Open	81.84
Previous Close	82.09
Day's Range	80.48 - 81.84
52-Week Low	39.47
52-Week High	90.91
Beta	1.36
Holdings	264
Inception Date	Apr 8, 2010

About BIB

Fund Home Page

The ProShares Ultra Nasdaq Biotechnology (BIB) is an exchange-traded fund that is based on the NASDAQ / Biotechnology index. The fund provides 2x daily exposure to a modified market-cap-weighted index of biotechnology and pharmaceutical companies listed on NASDAQ. BIB was launched on Apr 8, 2010 and is issued by ProShares.

Asset Class Equity

Category Trading--Leveraged Equity

Stock Exchange NASDAQ

Ticker Symbol BIB

ETF Provider ProShares

Index Tracked NASDAQ / Biotechnology

Top 10 Holdings

152.25% of assets

Name	Symbol	Weight
NASDAQ BIO INDEX SWAP BNP PARIBAS	n/a	35.99%
NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA	n/a	28.53%
NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA	n/a	27.16%
NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL	n/a	20.34%
NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE	n/a	16.97%
NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG	n/a	4.88%
Amgen Inc.	AMGN	4.82%
Gilead Sciences, Inc.	GILD	4.72%
Vertex Pharmaceuticals Incorporated	VRTX	4.71%
Regeneron Pharmaceuticals, Inc.	REGN	4.13%

View More Holdings

Dividend History

Ex-Dividend	Amount	Pay Date
Mar 25, 2026	$0.00714	Mar 31, 2026
Dec 24, 2025	$0.13464	Dec 31, 2025
Sep 24, 2025	$0.18054	Sep 30, 2025
Jun 25, 2025	$0.17058	Jul 1, 2025
Mar 26, 2025	$0.13094	Apr 1, 2025
Dec 23, 2024	$0.39644	Dec 31, 2024

Full Dividend History

Performance

BIB had a total return of 82.31% in the past year, including dividends. Since the fund's inception, the average annual return has been 16.26%.